INDUSATUMAB
UNII 731FA8A8YO

Substance Identification & Data

This profile provides standardized clinical and technical data for Indusatumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 731FA8A8YO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1497400-26-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
731FA8A8YO
CAS Registry Number
1497400-26-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
INDUSATUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10082
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Indusatumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INDUSATUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN GUANYLATE CYCLASE C) (HUMAN MONOCLONAL 5F9 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 5F9 .KAPPA.-CHAIN, DIMER
INDUSATUMAB [INN]

Technical Codes

5F9
HU5F9